3 January 2016
Comments are Off
Comments are closed.
Genoskin develops and markets innovative testing tools to study the effects of pharmaceutical, cosmetic and chemical products on real, live ex vivo human skin.
COVID-19 update: Genoskin expands R&D capabilities
8 April 2020
Genoskin maintains US lab activity amid COVID-19 pandemic
18 March 2020
Genoskin supports CoViD19 research!
13 March 2020
Top differences between human and animal skin
4 March 2020
6 steps to get your new product approved by FDA
28 February 2020